Prometheus Biosciences to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision...
Year: 2022
Mustang Bio to Participate in Three January 2022 Virtual Investor Conferences
WORCESTER, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
ABVC BioPharma Selects Additional Vitargus® Phase II Study Sites
Thailand Sites Join Australian Sites Confirmed to Participate in the Study Fremont, CA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via...
SELLAS Life Sciences Promotes John Burns to Senior Vice President, Finance and Chief Accounting Officer
NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a...
Shattuck Labs Announces Participation in Upcoming January Investor Conferences
AUSTIN, TX and DURHAM, NC, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (NASDAQ: STTK), a clinical-stage biotechnology company...
Lixte Biotechnology’s LB-100 Reported to Convert Immunologically Unresponsive (“Cold”) Tumors to Immunologically Responsive (“Hot”) Tumors
Outside research shows that in models of colorectal, triple-negative breast and pancreatic cancer, LB-100 induces molecular changes that render the cancers...
Marizyme Announces Allowance of Patent Application for Flagship Product DuraGraft by United States Patent and Trademark Office
Jupiter, FL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme, Inc. (“Marizyme” or the “Company”) (OTCQB: MRZM) is...
Agenus to Participate at Upcoming Investor Conferences
LEXINGTON, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint...
Hepion Pharmaceuticals to Present Clinical Data at NASH-TAG Conference
- Oral Presentation Chosen as a “Distinguished” Abstract -EDISON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA),...
Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing...
Clover Doses First Participants with Homologous Booster Dose of COVID-19 Vaccine Candidate in SPECTRA
SPECTRA has been amended to evaluate SCB-2019 (CpG 1018/Alum) as a homologous booster in approximately 4,000 adult participants previously vaccinated...
Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor
ACTON, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”) a late-stage, pre-revenue diagnostics/medical device company...
TRACON Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
HEXO Announces the Appointment of a New Board Member and Acting CFO
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 11, 2021...
Aileron Therapeutics Provides Business Update and Outlines 2022 Strategic Priorities to Deliver Key Milestones
Plans to initiate Phase 1b clinical trial of ALRN-6924 in neoadjuvant breast cancer in 1H22; interim results expected in 4Q22Planned...
Agile Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman...
Elucida Oncology Provides Corporate Update and Outlines Key Upcoming Milestones
Enrolling third dose level in Phase 1/2 dose escalation study of ELU001, our lead clinical program targeting solid tumors overexpressing...
Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect Virtual Conferences
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and...
Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma
AGOURA HILLS, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer...
Healthcare Integrated Technologies Receives Notice from USPTO Allowing SafeSpace™ Trademark
Trademark approved for “Medical alarm monitoring services for senior living in Class 45” Knoxville, Tennessee, Jan. 05, 2022 (GLOBE NEWSWIRE)...
